PULMONX CORPORATION Investment Income, Interest
PULMONX CORPORATION (LUNG) reported Investment Income, Interest of $329.00 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-04.
Financial Statements › Income Statement › Other Income
us-gaap:InvestmentIncomeInterest · last filed 2026-08-04
- PULMONX CORPORATION investment income, interest for the quarter ending 2026-06-30 was $329.00K, a 54.50% decline year-over-year.
- PULMONX CORPORATION investment income, interest for the quarter ending 2026-03-31 was $350.00K, a 59.49% decline year-over-year.
- PULMONX CORPORATION investment income, interest for the quarter ending 2025-12-31 was $453.00K, a 56.65% decline year-over-year.
- PULMONX CORPORATION investment income, interest for the quarter ending 2025-09-30 was $611.00K, a 51.85% decline year-over-year.
- PULMONX CORPORATION investment income, interest for fiscal 2025 was $2.65M, a 47.62% decline from fiscal 2024.
- PULMONX CORPORATION investment income, interest for fiscal 2024 was $5.06M, a 9.11% decline from fiscal 2023.
- PULMONX CORPORATION investment income, interest for fiscal 2023 was $5.57M, a 264.16% increase from fiscal 2022.
- PULMONX CORPORATION investment income, interest for fiscal 2022 was $1.53M, a 282.25% increase from fiscal 2021.
| Period end | Investment Income, Interest 3 month | Investment Income, Interest 6 month | Investment Income, Interest 9 month | Investment Income, Interest 12 month |
|---|---|---|---|---|
| 2026-06-30 | $329.00K 10-Q · filed 2026-08-04 | $679.00K 10-Q · filed 2026-08-04 | $1.13M derived: sum of 3 quarters · filed 2026-08-04 | $1.74M derived: sum of 4 quarters · filed 2026-08-04 |
| 2026-03-31 | $350.00K 10-Q · filed 2026-05-04 | $803.00K derived: sum of 2 quarters · filed 2026-05-04 | $1.41M derived: sum of 3 quarters · filed 2026-05-04 | $2.14M derived: sum of 4 quarters · filed 2026-08-04 |
| 2025-12-31 | $453.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-10 | $1.06M derived: sum of 2 quarters · filed 2026-03-10 | $1.79M derived: sum of 3 quarters · filed 2026-08-04 | $2.65M 10-K · filed 2026-03-10 |
| 2025-09-30 | $611.00K 10-Q · filed 2025-11-12 | $1.33M derived: sum of 2 quarters · filed 2026-08-04 | $2.20M 10-Q · filed 2025-11-12 | $3.24M derived: sum of 4 quarters · filed 2026-08-04 |
| 2025-06-30 | $723.00K 10-Q · filed 2026-08-04 | $1.59M 10-Q · filed 2026-08-04 | $2.63M derived: sum of 3 quarters · filed 2026-08-04 | $3.90M derived: sum of 4 quarters · filed 2026-08-04 |
| 2025-03-31 | $864.00K 10-Q · filed 2026-05-04 | $1.91M derived: sum of 2 quarters · filed 2026-05-04 | $3.18M derived: sum of 3 quarters · filed 2026-05-04 | $4.48M derived: sum of 4 quarters · filed 2026-05-04 |
| 2024-12-31 | $1.04M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-10 | $2.31M derived: sum of 2 quarters · filed 2026-03-10 | $3.62M derived: sum of 3 quarters · filed 2026-03-10 | $5.06M 10-K · filed 2026-03-10 |
| 2024-09-30 | $1.27M 10-Q · filed 2025-11-12 | $2.58M derived: sum of 2 quarters · filed 2025-11-12 | $4.02M 10-Q · filed 2025-11-12 | $5.56M derived: sum of 4 quarters · filed 2025-11-12 |
| 2024-06-30 | $1.31M 10-Q · filed 2025-08-01 | $2.75M 10-Q · filed 2025-08-01 | $4.29M derived: sum of 3 quarters · filed 2025-08-01 | $5.78M derived: sum of 4 quarters · filed 2025-08-01 |
| 2024-03-31 | $1.44M 10-Q · filed 2025-05-02 | $2.98M derived: sum of 2 quarters · filed 2025-05-02 | $4.47M derived: sum of 3 quarters · filed 2025-05-02 | $5.88M derived: sum of 4 quarters · filed 2025-05-02 |
| 2023-12-31 | $1.54M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-25 | $3.03M derived: sum of 2 quarters · filed 2025-02-25 | $4.44M derived: sum of 3 quarters · filed 2025-02-25 | $5.57M 10-K · filed 2025-02-25 |
| 2023-09-30 | $1.49M 10-Q · filed 2024-11-01 | $2.90M derived: sum of 2 quarters · filed 2024-11-01 | $4.03M 10-Q · filed 2024-11-01 | $4.78M derived: sum of 4 quarters · filed 2024-11-01 |
| 2023-06-30 | $1.41M 10-Q · filed 2024-08-02 | $2.54M 10-Q · filed 2024-08-02 | $3.29M derived: sum of 3 quarters · filed 2024-08-02 | $3.76M derived: sum of 4 quarters · filed 2024-08-02 |
| 2023-03-31 | $1.13M 10-Q · filed 2024-05-03 | $1.88M derived: sum of 2 quarters · filed 2024-05-03 | $2.35M derived: sum of 3 quarters · filed 2024-05-03 | $2.55M derived: sum of 4 quarters · filed 2024-05-03 |
| 2022-12-31 | $748.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-27 | $1.23M derived: sum of 2 quarters · filed 2024-02-27 | $1.42M derived: sum of 3 quarters · filed 2024-02-27 | $1.53M 10-K · filed 2024-02-27 |
| 2022-09-30 | $477.00K 10-Q · filed 2023-11-03 | $676.00K derived: sum of 2 quarters · filed 2023-11-03 | $781.00K 10-Q · filed 2023-11-03 | $875.00K derived: sum of 4 quarters · filed 2023-11-03 |
| 2022-06-30 | $199.00K 10-Q · filed 2023-08-04 | $304.00K 10-Q · filed 2023-08-04 | $398.00K derived: sum of 3 quarters · filed 2023-08-04 | $497.00K derived: sum of 4 quarters · filed 2023-08-04 |
| 2022-03-31 | $105.00K 10-Q · filed 2023-05-08 | $199.00K derived: sum of 2 quarters · filed 2023-05-08 | $298.00K derived: sum of 3 quarters · filed 2023-05-08 | $400.00K derived: sum of 4 quarters · filed 2023-05-08 |
| 2021-12-31 | $94.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-01 | $193.00K derived: sum of 2 quarters · filed 2023-03-01 | $295.00K derived: sum of 3 quarters · filed 2023-03-01 | $400.00K 10-K · filed 2023-03-01 |
| 2021-09-30 | $99.00K 10-Q · filed 2022-11-08 | $201.00K derived: sum of 2 quarters · filed 2022-11-08 | $306.00K 10-Q · filed 2022-11-08 | $421.00K derived: sum of 4 quarters · filed 2022-11-08 |
| 2021-06-30 | $102.00K 10-Q · filed 2022-08-08 | $207.00K 10-Q · filed 2022-08-08 | $322.00K derived: sum of 3 quarters · filed 2022-08-08 | $331.00K derived: sum of 4 quarters · filed 2022-08-08 |
| 2021-03-31 | $105.00K 10-Q · filed 2022-05-09 | $220.00K derived: sum of 2 quarters · filed 2022-05-09 | $229.00K derived: sum of 3 quarters · filed 2022-05-09 | $244.00K derived: sum of 4 quarters · filed 2022-05-09 |
| 2020-12-31 | $115.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-01 | $124.00K derived: sum of 2 quarters · filed 2022-03-01 | $139.00K derived: sum of 3 quarters · filed 2022-03-01 | $213.00K 10-K · filed 2022-03-01 |
| 2020-09-30 | $9.00K 10-Q · filed 2021-11-09 | $24.00K derived: sum of 2 quarters · filed 2021-11-09 | $98.00K 10-Q · filed 2021-11-09 | $220.00K derived: sum of 4 quarters · filed 2021-11-09 |
| 2020-06-30 | $15.00K 10-Q · filed 2021-08-10 | $89.00K 10-Q · filed 2021-08-10 | $211.00K derived: sum of 3 quarters · filed 2021-08-10 | $378.00K derived: sum of 4 quarters · filed 2021-08-10 |
| 2020-03-31 | $74.00K 10-Q · filed 2021-05-12 | $196.00K derived: sum of 2 quarters · filed 2021-05-12 | $363.00K derived: sum of 3 quarters · filed 2021-05-12 | |
| 2019-12-31 | $122.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-15 | $289.00K derived: sum of 2 quarters · filed 2021-03-15 | $432.00K 10-K · filed 2021-03-15 | |
| 2019-09-30 | $167.00K 10-Q · filed 2020-11-13 | $310.00K 10-Q · filed 2020-11-13 | ||
| 2018-12-31 | $21.00K 10-K · filed 2021-03-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| SkinHealth Systems Inc. (SKIN) | United States | $0.086B | -3.17 |
| LENSAR, Inc. (LNSR) | United States | $0.087B | 2.02 |
| RenovoRx, Inc. (RNXT) | United States | $0.076B | -3.62 |
| Microbot Medical Inc. (MBOT) | $0.089B | -7.97 | |
| FRACTYL HEALTH, INC. (GUTS) | United States | $0.075B | -1.18 |
| CVRx, Inc. (CVRX) | United States | $0.067B | -2.62 |
| DarioHealth Corp. (DRIO) | $0.066B | -1.39 | |
| TELA Bio, Inc. (TELA) | United States | $0.057B | -0.82 |
| Xtant Medical Holdings, Inc. (XTNT) | United States | $0.053B | |
| Spectral AI, Inc. (MDAI) | United States | $0.052B |